HCG Weight Loss

HCG Weight Loss operates as a telehealth-focused weight management clinic serving patients throughout Las Vegas, Nevada, with lead provider Mia LoPrieto directing clinical protocols centered on pharmacological appetite regulation and metabolic optimization. The clinic has transitioned its treatment model to emphasize GLP-1 receptor agonist therapy, specifically semaglutide, as a primary intervention for patients struggling with obesity, metabolic syndrome, and weight-related health complications. Unlike traditional weight loss programs that rely solely on caloric restriction or exercise mandates, HCG Weight Loss structures its protocols around the physiological mechanisms of appetite suppression and insulin sensitivity improvement that semaglutide provides, allowing patients to achieve sustainable weight reduction through hormonal pathway modulation rather than willpower alone.

Semaglutide therapy at HCG Weight Loss follows evidence-based dosing protocols that begin with low introductory doses to minimize gastrointestinal side effects while gradually escalating to therapeutic levels over several weeks. Mia LoPrieto works with patients to establish individualized dosing schedules based on tolerance profiles, weight loss velocity, and metabolic response markers. The clinic monitors patients for common semaglutide-related effects including nausea, constipation, and appetite changes, adjusting protocols as needed to maintain treatment adherence. Patients receive detailed guidance on injection technique, medication storage, and timing relative to meals to optimize absorption and minimize discomfort. The program includes regular metabolic assessments to track changes in fasting glucose, hemoglobin A1c, lipid panels, and body composition metrics beyond simple scale weight, providing patients with comprehensive data on their metabolic health improvements throughout treatment.

Mia LoPrieto brings clinical expertise in weight management pharmacology and metabolic disorders to her role at HCG Weight Loss, focusing her practice on patients who have experienced repeated failures with conventional diet programs or who present with obesity-related comorbidities requiring medical intervention. Her approach emphasizes patient education on the neurohormonal mechanisms underlying appetite dysregulation and how GLP-1 agonists restore satiety signaling that becomes disrupted in chronic obesity. LoPrieto conducts thorough intake assessments to identify contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, or active gallbladder disease that would preclude semaglutide use. She also evaluates medication interactions, particularly with insulin or sulfonylureas in diabetic patients, adjusting concurrent therapies to prevent hypoglycemia as weight loss progresses and insulin sensitivity improves.

Patients beginning treatment with HCG Weight Loss in Las Vegas complete an initial telehealth consultation where medical history, current medications, weight loss history, and metabolic health markers are reviewed to determine candidacy for semaglutide therapy. Following approval, patients receive their medication through partner pharmacies with detailed administration instructions and access to ongoing clinical support through the telehealth platform. The clinic schedules regular follow-up appointments at two to four week intervals during the initial titration phase, then monthly once therapeutic dosing is established. These check-ins assess weight trends, side effect management, adherence challenges, and metabolic marker changes while providing accountability and clinical guidance. LoPrieto addresses common patient concerns including weight loss plateaus, social eating situations, and the psychological aspects of appetite changes that occur with GLP-1 therapy, helping patients develop sustainable eating patterns that will support long-term weight maintenance.

The telehealth delivery model employed by HCG Weight Loss eliminates geographic barriers for Nevada residents seeking medical weight loss treatment, particularly benefiting patients in Las Vegas and surrounding communities who face scheduling constraints or mobility limitations that make in-person appointments challenging. Virtual consultations allow for flexible appointment times while maintaining the clinical rigor of traditional medical weight management programs. The clinic provides patients with written treatment protocols, educational resources on metabolic health, and direct communication channels for urgent questions or side effect concerns between scheduled appointments. This accessibility-focused approach has contributed to the clinic's perfect rating from patients who value the combination of medical expertise and convenience that telehealth semaglutide programs provide for individuals committed to addressing obesity through evidence-based pharmacological intervention.